FibroGen Stock Soars 30% In 21 Sessions: Is It A Buy?
(VIANEWS) – FibroGen (NASDAQ: FGEN) experienced an unprecedented 30.98% surge over the past 21 sessions, rising from EUR1.98 on February 28th to EUR2.59 at 12:57 EST Tuesday at 12:57, marking five straight sessions of gains. Meanwhile, NASDAQ is also showing signs of life with its Index currently up 0.39% at EUR16,447.96; FibroGen’s last close price…